UPDATE : Friday, May 29, 2020
MGmed emerges as largest shareholder of UK bio venture
MGmed said it has emerged as the largest stakeholder of Oxford Vacmedix (OV...
by Marian Chu  |  2017-12-06 13:00
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun  |  2017-12-06 09:30
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo  |  2017-12-05 15:40
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo  |  2017-12-04 16:17
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
Nature Cell’s clinical trial on Alzheimer therapy running smoothly
Nature Cell said Monday that it has injected 10 doses of Astrostem, a stem-...
by Lee Han-soo  |  2017-12-04 14:57
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment
Pharmicell said Monday that the U.S. Food and Drug Administration has appro...
by Lee Han-soo  |  2017-12-04 14:57
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun  |  2017-12-01 11:48
Panagene wins patent for molecular diagnostic platform
Panagene said Thursday that it has completed its patent registration for PA...
by Lee Han-soo  |  2017-12-01 11:02
Medipost hits record vial sales for Cartistem
Medipost said Thursday that it hit record sales of 266 vials for Cartistem,...
by Lee Han-soo  |  2017-11-30 16:16
Biopharmaceutical firms' liver treatments draw attention
Local biopharmaceutical companies, including Sillajen, HLB, and Pharmicell,...
by So Jae-hyeon  |  2017-11-30 12:02
What are doctors’ views on Invossa used even by foreign patients?
An increasing number of patients here are trying to obtain Invossa-K, an os...
by Lee Hye-seon  |  2017-11-29 09:31
Green Cross, Feldan start joint tech development
Green Cross Labcell and Feldan Therapeutics, a Canadian biotechnology compa...
by Lee Han-soo  |  2017-11-27 16:59
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun  |  2017-11-27 13:13
Biogen Korea taps new CEO
Biogen Korea, the Korean branch of the American multinational biotech Bioge...
by Marian Chu  |  2017-11-27 11:57
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun  |  2017-11-24 15:53
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
The Ministry of Food and Drug Safety (MFDS) has approved Kolon Life Science...
by Lee Han-soo  |  2017-11-23 15:53
GemVax & KAEL confirms potential tracer effective to reperfusion injury
A study conducted by the Seoul National University has confirmed that GV100...
by Constance Williams  |  2017-11-22 15:51
COGIB spotlights future of innovative biotherapeutic
The Coordinating Center for Global Innovative Biotherapeutics (COGIB) analy...
by Lee Han-soo  |  2017-11-22 11:06
Back to Top